NLINKN1 Chip+PRIME.StudySYNCRStentrode+$75M.SeriesDPRECNLayer 7+FDA.BrkthruPARAMArgo+$20M.SeriesBBLKRKNeuroport+200.ImplantsEMTIVMN8+$45M.SeriesBKRNLFlux+Non-invasiveNRBLEHalo+Consumer.BCINEURONeuroPace+RNS.SystemCOGNICognixion+ALS.TrialFUND.YTD2026$2.8B.SectorTRIALSActive50+.ClinTrialsIMPLNTSHumans~100.Intracrtnl
Terminal/Companies/BrainGate Consortium
activeFounded 2004

BrainGate Consortium

HQ: Providence, RI, USACEO: Leigh Hochberg (PI); John Donoghue (founder)braingate.org
About

BrainGate is the world's longest-running academic BCI consortium, comprising Brown University, Stanford University, Case Western Reserve University, and Massachusetts General Hospital. The BrainGate2 trial has enrolled more than 30 participants since 2004 and has produced many of the field's seminal publications, including robotic arm control for self-feeding (Nature, 2012), wireless intracortical BCI (IEEE TNSRE, 2021), and 62 WPM typing by imagined handwriting (Nature, 2021). BrainGate is research-only and does not commercialize devices, instead serving as the foundational evidence base for the clinical BCI field.

Products
braingate-system
Recent Developments
Recent developments are auto-populated from tagged articles in the Newsfeed. Browse all news →